| Microba Life Sciences Limited (MAP) ORDINARY FULLY PAID |
Health Care |
$40 |
Q1 FY25 Quarterly Activities Report & Appendix 4C
|
29 Oct 2024 9:15AM |
$0.160 |
$0.090 |
fallen by
43.75%
|
|
MAP - Price-sensitive ASX Announcement
Full Release
Key Points
- Cash receipts of $5.07m, up 184% vs Previous Corresponding Period.
- Revenue of $3.65m, up 239% vs PCP.
- MetaXplore tests sold reached a Q1 annualised run rate of 7,328.
- First orders of MetaXplore in the United Kingdom received post quarter end.
- MAP 315 advancing towards Phase 2 clinical trial.
- $16.4m in cash or equivalents at end of Q1 FY25.
- Strong start in Q2 with record sales month in October.
- Strategic appointments to accelerate growth momentum.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Microba Life Sciences Limited (MAP) ORDINARY FULLY PAID |
Health Care |
$40 |
Q1 FY25 Quarterly Investor Presentation
|
29 Oct 2024 9:15AM |
$0.160 |
$0.090 |
fallen by
43.75%
|
|
MAP - Price-sensitive ASX Announcement
Full Release
Key Points
- Microba reported record Q1 revenue of $3.65 million, up 239% vs PCP.
- MetaXplore sales momentum continues to accelerate in Australia.
- First orders for MetaXplore received in the UK as part of the transition to a growth phase.
- Significant growth in the number of ordering clinicians, with a 101% increase in tests sold.
- Advancements in therapeutic programs for Inflammatory Bowel Disease, Immuno-Oncology, and Autoimmune diseases.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana Global Private Credit Trust (PCX) ORDINARY UNITS FULLY PAID |
Financials |
$164 |
PCX Webinar Presentation
|
29 Oct 2024 9:14AM |
$2.020 |
$2.000 |
fallen by
0.99%
|
|
| Orion Minerals Ltd (ORN) ORDINARY FULLY PAID |
Materials |
$69 |
Progress Update Feasibility Studies for Prieska and Okiep
|
29 Oct 2024 9:14AM |
$0.019 |
$0.010 |
fallen by
47.37%
|
|
ORN - Price-sensitive ASX Announcement
Full Release
Key Points
- Nick Fouche appointed as PCZM Project Director.
- LMMS Consultants engaged for final stages of the PCZM Feasibility Study.
- Internal review identified potential optimizations for the PCZM project.
- Final PCZM feasibility study to be delivered in Q1 2025.
- Flat Mines Project feasibility study expected to begin external review in November 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MEC Resources Limited (MMR) ORDINARY FULLY PAID |
Energy |
$9 |
AGM documents access letter
|
29 Oct 2024 9:13AM |
$0.004 |
$0.005 |
risen by
25%
|
|
| Elanor Commercial Property Fund (ECF) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$256 |
Successful Completion of Entitlement Offer
|
29 Oct 2024 9:13AM |
$0.590 |
$0.630 |
risen by
6.78%
|
|
| MEC Resources Limited (MMR) ORDINARY FULLY PAID |
Energy |
$9 |
Notice of Annual General Meeting/Proxy Form
|
29 Oct 2024 9:13AM |
$0.004 |
$0.005 |
risen by
25%
|
|
| Trajan Group Holdings Limited (TRJ) ORDINARY FULLY PAID |
Health Care |
$111 |
Business Update
|
29 Oct 2024 9:13AM |
$1.200 |
$0.730 |
fallen by
39.17%
|
|
TRJ - Price-sensitive ASX Announcement
Full Release
Key Points
- Total Net Revenue up high single digit over prior comparative period.
- Capital Equipment food sector demonstrating strong growth contributing to total Segment revenue up 15% in Q1 over prior comparative period.
- Order demand increasing for Trajan’s MOSH/MOAH food safety instrument systems.
- US FDA purchased Trajan’s MOSH/MOAH instrument system in Q1.
- Pharmaceutical Sector continues to be soft.
- Single digit growth in Components and Consumables over prior comparative period.
- FY2025 Guidance maintained; Net Revenue of $160.0M to $165.0M, Group nEBITDA of $17.0 to $19.0M.
- Completion of small acquisition of Mass Spec Studio data processing software platform from University of Calgary.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WCM Global Growth Limited (WQG) ORDINARY FULLY PAID |
Financials |
$401 |
Weekly NTA 25 October 2024
|
29 Oct 2024 9:12AM |
$1.660 |
$1.770 |
risen by
6.63%
|
|
| DigitalX Limited (DCC) ORDINARY FULLY PAID |
Information Technology |
$85 |
Microcap Investment Conference 2024 Presentation
|
29 Oct 2024 9:12AM |
$0.038 |
$0.071 |
risen by
86.84%
|
|
| Ashley Services Group Limited (ASH) ORDINARY FULLY PAID |
Industrials |
$24 |
Notice of Annual General Meeting
|
29 Oct 2024 9:12AM |
$0.195 |
$0.165 |
fallen by
15.38%
|
|
| Trajan Group Holdings Limited (TRJ) ORDINARY FULLY PAID |
Health Care |
$111 |
2024 Annual General Meeting Chair Address and Presentation
|
29 Oct 2024 9:10AM |
$1.200 |
$0.730 |
fallen by
39.17%
|
|
| Sandfire Resources Limited (SFR) ORDINARY FULLY PAID |
Materials |
$5,041 |
Sandfire September 2024 Quarterly Report
|
29 Oct 2024 9:10AM |
$10.770 |
$10.980 |
risen by
1.95%
|
|
SFR - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported a marginal increase in Total Recordable Injury Frequency (TRIF) to 1.8.
- Received environmental approval for a new tailings facility at MATSA.
- Maintained Group Copper Equivalent production at 38.0kt.
- Increased CuEq production by 4% at MATSA in Q1 FY25.
- Sustained an annualised processing rate of 5.3Mt at Motheo.
- Achieved an Underlying Operating Cost of $40/t of ore processed at Motheo.
- Generated unaudited Group sales revenue of $282M.
- Reduced unaudited net debt to $345M at 30 September 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Streamplay Studio Limited (SP8) ORDINARY FULLY PAID |
Communication Services |
$9 |
Notice of Annual General Meeting/Proxy Form
|
29 Oct 2024 9:10AM |
$0.007 |
$0.007 |
fallen by
0%
|
|
| BlinkLab Limited (BB1) ORDINARY FULLY PAID |
Health Care |
$44 |
AusBioInvest, JMM Lunch, BioFuture - Investor Presentation
|
29 Oct 2024 9:09AM |
$0.260 |
$0.510 |
risen by
96.15%
|
|
| InhaleRx Limited (IRX) ORDINARY FULLY PAID |
Health Care |
$10 |
General Meeting - Access Letter
|
29 Oct 2024 9:09AM |
$0.030 |
$0.048 |
risen by
60%
|
|
| InhaleRx Limited (IRX) ORDINARY FULLY PAID |
Health Care |
$10 |
Notice of General Meeting
|
29 Oct 2024 9:08AM |
$0.030 |
$0.048 |
risen by
60%
|
|
| Saferoads Holdings Limited (SRH) ORDINARY FULLY PAID |
Industrials |
$4 |
Monthly Activities/Appendix 4C Cash Flow Report
|
29 Oct 2024 9:08AM |
$0.041 |
$0.088 |
risen by
114.63%
|
|
SRH - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash from operating activities was $815,000.
- Total receipts from customers amounted to $3,393,000.
- Manufacturing and operating costs totaled $1,156,000.
- Staff costs were recorded at $825,000.
- Net cash used in investing activities was $136,000.
- Net cash used in financing activities amounted to $621,000.
- The report indicates a net decrease in cash and cash equivalents.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MRG Metals Limited (MRQ) ORDINARY FULLY PAID |
Materials |
$10 |
MRG HMS - Corridor North & Marao Auger Drilling to Commence
|
29 Oct 2024 9:07AM |
$0.003 |
$0.004 |
risen by
16.67%
|
|
MRQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Auger drilling at Corridor North and Marao to commence.
- Corridor North will be the first exploration activity on the license.
- Marao will focus on infill drilling at the Magonde high-grade HMS target.
- The drilling is funded under a joint venture with Sinowin.
- The initiative is aimed at expanding heavy mineral concentrate production.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Moab Minerals Limited (MOM) ORDINARY FULLY PAID |
Materials |
$2 |
Trading Halt
|
29 Oct 2024 9:06AM |
$0.004 |
$0.001 |
fallen by
75%
|
|
MOM - Price-sensitive ASX Announcement
Full Release
Key Points
- Moab Minerals Limited requested a trading halt.
- The trading halt is effective from 29 October 2024.
- The halt is pending an announcement regarding a proposed capital raising.
- Trading will resume on 31 October 2024 or upon announcement release.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alvo Minerals Limited (ALV) ORDINARY FULLY PAID |
Materials |
$3 |
Investor Presentation - IMARC Sydney
|
29 Oct 2024 9:06AM |
$0.094 |
$0.022 |
fallen by
76.60%
|
|
| InhaleRx Limited (IRX) ORDINARY FULLY PAID |
Health Care |
$10 |
General Meeting - Sample Proxy
|
29 Oct 2024 9:06AM |
$0.030 |
$0.048 |
risen by
60%
|
|
| Morphic Ethical Equities Fund Limited (MEC) ORDINARY FULLY PAID |
Financials |
$36 |
Update - Notification of buy-back - MEC
|
29 Oct 2024 9:06AM |
$0.995 |
$1.045 |
risen by
5.03%
|
|
| PainChek Ltd (PCK) ORDINARY FULLY PAID |
Health Care |
$63 |
Positive study results pave way for PainChek FDA submission
|
29 Oct 2024 9:06AM |
$0.028 |
$0.034 |
risen by
21.43%
|
|
PCK - Price-sensitive ASX Announcement
Full Release
Key Points
- Positive validation study results for the PainChek Adult App.
- FDA submission expected in November 2024.
- Study included 105 residents from nursing homes in Iowa and New York.
- PainChek aims to penetrate the U.S. aged care market.
- Potential annual revenue of around $85 million USD for PainChek.
- PainChek Adult App would be the first FDA-cleared pain assessment tool for dementia patients.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BETR Entertainment Limited (BBT) ORDINARY FULLY PAID |
Consumer Discretionary |
$267 |
Notice of Annual General Meeting & Proxy Form
|
29 Oct 2024 9:05AM |
$0.235 |
$0.260 |
risen by
10.64%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
